SCHEMBL6833933

SCHEMBL6833933

N#Cc1ccc(NC(=O)c2cc(-c3ccccc3Cl)on2)c(C(=O)O)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 11/20 0.54
MEN1 O00255 8/20 0.54
KMT2A Q03164 8/20 0.54
RAB9A P51151 8/20 0.54
HCRTR1 O43613 1/20 0.54
HPGD P15428 6/20 0.54
L3MBTL1 Q9Y468 2/20 0.50
ALDH1A1 P00352 4/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C19 P33261 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
KDM4E B2RXH2 2/20 0.45
LMNA P02545 1/20 0.45
EPAS1 Q99814 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.44
MAPT P10636 2/20 0.44
NPY1R P25929 1/20 0.44
NPY2R P49146 1/20 0.44
ALB P02768 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6833885 0.90 TDP1 (0.49) NPC1MEN1KMT2ARAB9AHPGD
SCHEMBL6833848 0.90 KMT2A (0.56) NPC1MEN1KMT2ARAB9AHCRTR1
SCHEMBL6813586 0.89 ALDH1A1 (0.44) NPC1MEN1KMT2ARAB9AHCRTR1
SCHEMBL6834026 0.89 KMT2A (0.46) NPC1MEN1KMT2ARAB9AHCRTR1
SCHEMBL6830647 0.89 KMT2A (0.49) NPC1MEN1KMT2ARAB9AHCRTR1
SCHEMBL6813729 0.87 TDP1 (0.55) NPC1MEN1KMT2ARAB9AALDH1A1
SCHEMBL6833999 0.87 NPC1 (0.61) NPC1MEN1KMT2ARAB9AHCRTR1
SCHEMBL6817690 0.86 HSD17B10 (0.62) NPC1MEN1KMT2ARAB9AHPGD
SCHEMBL6818899 0.86 KMT2A (0.57) NPC1MEN1KMT2ARAB9AHCRTR1
SCHEMBL6818833 0.85 PYGL (0.49) NPC1MEN1KMT2ARAB9AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040110802-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110802-A1 Antibacterial benzoic acid derivatives GABRD, GABBR1, GABRA1 NPC1 3778/4885MEN1 4132/4885KMT2A 2853/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.